The systemic activation of macrophages by liposomes containing immunomodulators.
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000627:therapeutic use; D000818:Animals; D003602:Cytotoxicity, Immunologic; D006801:Humans; D007167:Immunotherapy; D008081:Liposomes / Q000008:administration & dosage*; D008262:Macrophage Activation; D009369:Neoplasms / Q000276:immunology / Q000628:therapy; D010587:Phagocytosis
D008081:Liposomes; D000119:Acetylmuramyl-Alanyl-Isoglutamine